-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JzDw8VCwDA55cBJVYPeYH1CJCEjDeeE5ekILqA6bi7CO9nbRpYfNJ9hYTCoegjNs LUo521WQOq9/8mdEjTy7NA== 0001140361-08-015897.txt : 20080627 0001140361-08-015897.hdr.sgml : 20080627 20080627164056 ACCESSION NUMBER: 0001140361-08-015897 CONFORMED SUBMISSION TYPE: NT 20-F PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071231 FILED AS OF DATE: 20080627 DATE AS OF CHANGE: 20080627 EFFECTIVENESS DATE: 20080627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOIL BIOGENICS LTD CENTRAL INDEX KEY: 0001049576 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 650401897 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 000-26531 FILM NUMBER: 08923080 BUSINESS ADDRESS: STREET 1: MARQUES DE URQUIJO 5, 5 B STREET 2: MADRID SPAIN CITY: 28008 STATE: U3 ZIP: 00000 BUSINESS PHONE: 34-91-548-7705 MAIL ADDRESS: STREET 1: MARQUES DE URQUIJO 5, 5 B STREET 2: MADRID SPAIN CITY: 28008 STATE: U3 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: PATAGONIA GOLD CORP DATE OF NAME CHANGE: 20010705 NT 20-F 1 doc1.htm Form 12b-25: Notification of Late Filing

United States
Securities and Exchange Commission
Washington, D.C. 20549

FORM 12b-25

Notification of Late Filing

(Amendment No. 0)*

OMB Number
3234-0058 		SEC File Number
000-26531		CUSIP Number
G82526 10 7
(Check one):   Form 10-K √ Form 20-F   Form 11-K   Form 10-Q   Form 10-D   Form N-SAR
  Form N-CSR
For Period Ended:December 31, 2007  
  Transition Report on Form 10-K
  Transition Report on Form 20-F
  Transition Report on Form 11-K
  Transition Report on Form 10-Q
  Transition Report on Form N-SAR
For the Transition Period Ended:  

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 

Part I - Registrant Information

Soil Biogenics Limited
Full Name of Registrant
 
Former Name if Applicable
Marques de Urquijo 5, 5 B,
Address of Principal Executive Office (Street and Number)
28008, Madrid, Spain
City, State and Zip Code

Part II - Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.(Check box if appropriate.)

√

(a)The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.
(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

Part III - Narrative

State below i n reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Due to delays in receiving certain information, the report on Form 20-F could not be timely filed without unreasonable effort or expense

Part IV - Other Information

  1. Name and telephone number of person to contact in regard to this notification

    Cameron Richardson604687-4432
    (Name)(Area Code)(Telephone Number)

  2. Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?

    Yes  √  No   
    If answer is no, identify report(s).
     

  3. Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

    Yes     No  √
    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
     
Soil Biogenics Limited
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized

Date:06-27-2008By /s/Cameron RichardsonTitle:Controller

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

Attention

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

 -----END PRIVACY-ENHANCED MESSAGE-----